Skip to main content

Table 1 Patient demographics and clinical characteristics

From: Multi-country clinical practice patterns, including use of biomarkers, among physicians’ treatment of BCG-unresponsive non-muscle invasive bladder cancer (NMIBC)

Demographics and clinical characteristics

n = 2554

Age (years), mean (SD)

71.5 (9.9)

Gender (male), n (%)

1978 (77.4)

BMI, mean (SD)

25.9 (4.5)

Risk classification at diagnosis, n (%)

 High

1248 (48.9)

 Intermediate

1306 (51.2)

ECOG at initial NMIBC diagnosis, n (%)

 0

1209 (47.3)

 1

805 (31.5)

 ≥ 2

488 (19.0)

Unknown/not assessed

52 (2.0)

Number of tumors at most recent assessment, n (%)

 1

963 (37.7)

 2 − 7

1419 (55.6)

 > 8

172 (6.7)

Time since diagnosis (years), mean (SD)

1.9 (2.5)

Staging at diagnosis, n (%)

 CIS alone

871 (34.1)

 Papillary alone

859 (33.6)

 Papillary + CIS

824 (32.3)

  1. BMI: body mass index; CIS: carcinoma in situ; ECOG: Eastern Cooperative Oncology Group; NMIBC: non-muscle invasive bladder cancer; SD: standard deviation